Analysis of Pre-Analytic Factors Affecting the Success of Clinical Next-Generation Sequencing of Solid Organ Malignancies
Application of next-generation sequencing (NGS) technology to routine clinical practice has enabled characterization of personalized cancer genomes to identify patients likely to have a response to targeted therapy. The proper selection of tumor sample for downstream NGS based mutational analysis is...
Main Authors: | Hui Chen, Rajyalakshmi Luthra, Rashmi S. Goswami, Rajesh R. Singh, Sinchita Roy-Chowdhuri |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2015-08-01
|
Series: | Cancers |
Subjects: | |
Online Access: | http://www.mdpi.com/2072-6694/7/3/0859 |
Similar Items
-
Next-Generation Sequencing in Clinical Molecular Diagnostics of Cancer: Advantages and Challenges
by: Rajyalakshmi Luthra, et al.
Published: (2015-10-01) -
Prevalence of PIK3CA mutations in Taiwanese patients with breast cancer: a retrospective next-generation sequencing database analysis
by: Ta-Chung Chao, et al.
Published: (2023-08-01) -
The Progress of Next Generation Sequencing in the Assessment of Myeloid Malignancies
by: Fulya Öz Puyan, et al.
Published: (2019-03-01) -
A novel hotspot and rare somatic mutation p.A138V, at TP53 is associated with poor survival of pancreatic ductal and periampullary adenocarcinoma patients
by: Gourab Saha, et al.
Published: (2020-06-01) -
HotSPOT: A Computational Tool to Design Targeted Sequencing Panels to Assess Early Photocarcinogenesis
by: Sydney R. Grant, et al.
Published: (2023-03-01)